Export

EN
FR
Levetiracetam
Essential medicine status
Section:
5. Medicines for neurological disorders 5.1. Medicines for central nervous system disorders 5.1.1. Antiseizure medicines
ATC codes: N03AX14
EMLc
Indication
Status epilepticus ICD11 code: 8A66
INN
Levetiracetam
Medicine type
Chemical agent
List type
Complementary (EML)
(EMLc)
Formulations
Parenteral > General injections > IV: 100 mg per mL in 5 mL ampoule or vial ; 5 mg per mL in 100 mL bag ; 10 mg per mL in 100 mL bag ; 15 mg per mL in 100 mL bag
EML status history
First added in 2023 (TRS 1049)
Changed in 2025 (TRS 1064)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Wikipedia
Levetiracetam
DrugBank
Levetiracetam
Summary of evidence and Expert Committee recommendations
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended: - to modify the formulation descriptions to better describe the available dosage forms.